Table 2. Current recommendation of... | American Society of Hematology

Table 2.

Current recommendation of antithrombotic treatments in LVAD and TAH

	Antithrombotic treatment	Initiation	Duration/survey
LVAD	UFH	As soon as drains allow anticoagulation	Stop when INR > 2
	Warfarin	After drain removal	2 < INR < 3 long-term treatment
	Aspirin	Around day 2	Long-term treatment
SynCardia	UFH	After surgery as soon as possible	Stop when INR >2
	Warfarin	After drain removal	2.5 < INR < 3.5 long-term treatment
	Aspirin	Around day 2	Long-term treatment
Aeson	UFH	As soon as drains allow anticoagulation	Anti-Xa around 0.2 until drain removal
	LMWH	After drain removal	No biological follow-up long-term treatment
	Aspirin	At least 4 d after drain removal	Long-term treatment

	Antithrombotic treatment	Initiation	Duration/survey
LVAD	UFH	As soon as drains allow anticoagulation	Stop when INR > 2
	Warfarin	After drain removal	2 < INR < 3 long-term treatment
	Aspirin	Around day 2	Long-term treatment
SynCardia	UFH	After surgery as soon as possible	Stop when INR >2
	Warfarin	After drain removal	2.5 < INR < 3.5 long-term treatment
	Aspirin	Around day 2	Long-term treatment
Aeson	UFH	As soon as drains allow anticoagulation	Anti-Xa around 0.2 until drain removal
	LMWH	After drain removal	No biological follow-up long-term treatment
	Aspirin	At least 4 d after drain removal	Long-term treatment

LMWH, low molecular weight heparin; UFH, unfractionated heparin; LVAD, left ventricular assistance device; INR, International normalized ratio.